RAMPs on Trial

Click to view a PDF of antimicrobial peptides in various living organisms (141K) Living organisms produce a vast array of germ-killing peptides as their first-line of defense against infection. Scientists began to learn of these molecules in the 1980s from studies by Hans Boman and colleagues at the University of Stockholm, Sweden. They found that silkworm moth pupae secrete certain peptides that destroy invading bacteria. These controversial peptides (see Antibiotic Arms Race Heats Up) are

Jack Lucentini
Sep 7, 2003

Living organisms produce a vast array of germ-killing peptides as their first-line of defense against infection. Scientists began to learn of these molecules in the 1980s from studies by Hans Boman and colleagues at the University of Stockholm, Sweden. They found that silkworm moth pupae secrete certain peptides that destroy invading bacteria.

These controversial peptides (see Antibiotic Arms Race Heats Up) are called ribosomally synthesized antimicrobial peptides, or RAMPs. This illustration describes RAMPs currently or recently tested as antibiotics in clinical trials.

Compiled by Jack Lucentini (Jekluc@aol.com)


Please indicate on a 1 - 5 scale how strongly you would recommend this article to your colleagues?
Not recommended
1
2
3
4
5
   Highly recommended
Please register your vote

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?